ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2003
Safety and efficacy evaluation of pleconaril for treatment of the common cold.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 37 citations in OpenAlex.
- Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Synthesis and Structure-Activity Relationship (SAR) Studies of Novel Pyrazolopyridine Derivatives as Inhibitors of Enterovirus Replication.Journal of medicinal chemistry · 2018Article
- Article
- Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses.Antimicrobial agents and chemotherapy · 2015Article
- Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3.Journal of ginseng research · 2014Article
- Antiviral Activity of Hederasaponin B from Hedera helix against Enterovirus 71 Subgenotypes C3 and C4a.Biomolecules & therapeutics · 2014Article
- Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections.ACS medicinal chemistry letters · 2013Article
- An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.PLoS pathogens · 2013Article
- Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution.Science (New York, N.Y.) · 2009Article
- Severe childhood respiratory viral infections.Advances in pediatrics · 2009Review
- Host immune responses to rhinovirus: mechanisms in asthma.The Journal of allergy and clinical immunology · 2008Review
- Respiratory viruses other than influenza virus: impact and therapeutic advances.Clinical microbiology reviews · 2008Review
- Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.Proceedings of the American Thoracic Society · 2007Review
- Rhinovirus chemotherapy.Antiviral research · 2006Review
- Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.Antimicrobial agents and chemotherapy · 2005Article
Corrections and comments
- Comment on
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.